ArticleArchives of microbiology2025
New observations in the spores and hyphae of Colletotrichum siamense exposed to nanochitosan particles.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Colletotrichum siamense is a complex phytopathogen within the Colletotrichum gloeosporioides species, responsible for anthracnose disease in horticultural crops, leading to significant economic losses. Synthetic fungicides are frequently used for control; however, their overuse has resulted in fungal resistance and environmental contamination due to residues accumulation, underscoring the necessity for safer and more effective alternatives. Chitosan nanoparticles provide a feasible alternative with notable antifungal activity against various phytopathogenic fungi. Nonetheless, despite their efficacy against numerous fungi, certain species within the C. gloeosporioides complex have demonstrated reduced susceptibility to the biopolymer, suggesting potential adaptation mechanisms to chitosan nanoparticles. This study assessed the in vitro antifungal efficacy of chitosan nanoparticles against C. siamense. The findings indicated that the biopolymer suppressed mycelial growth by 21.73%. The germination of the spores was delayed by 2 h, accompanied by a decrease in germinative tube length relative to the control group. Nevertheless, an acceleration in growth was observed, resulting in 100% of the spores germinating concurrently with the control group. Furthermore, it was noted that the integrity of both the plasmatic membrane and the cell wall was compromised by the nanochitosan. These findings facilitate the investigation of potential adaptive or defensive mechanisms that C. siamense may employ in response to nanochitosan, offering novel insights for disease management.
Indexed as
Identifiers
40928516What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.